Residential College | false |
Status | 已發表Published |
TNF compromises intestinal bile-acid tolerance dictating colitis progression and limited infliximab response | |
Zheng, Mengqi1,2; Zhai, Yunjiao3; Yu, Yanbo1,2,4,5; Shen, Jing3; Chu, Shuzheng3; Focaccia, Enrico6; Tian, Wenyu3; Wang, Sui1; Liu, Xuesong3; Yuan, Xi3; Wang, Yue1; Li, Lixiang1,2,4,5; Feng, Bingcheng1; Li, Zhen1,2,4,5; Guo, Xiaohuan7,14; Qiu, Ju8; Zhang, Cuijuan9,15; Hou, Jiajie10,16; Sun, Yiyuan1; Yang, Xiaoyun1,2,4,5; Zuo, Xiuli1,2,4,5; Heikenwalder, Mathias6,11; Li, Yanqing1,2,4,5; Yuan, Detian12; Li, Shiyang1,2,3,13 | |
2024-09-03 | |
Source Publication | Cell Metabolism |
ISSN | 1550-4131 |
Volume | 36Issue:9Pages:2086-2103 |
Other Abstract | SUMMARY The intestine constantly encounters and adapts to the external environment shaped by diverse dietary nutrients. However, whether and how gut adaptability to dietary challenges is compromised in ulcerative colitis is incompletely understood. Here, we show that a transient high-fat diet exacerbates colitis owing to inflammation-compromised bile acid tolerance. Mechanistically, excessive tumor necrosis factor (TNF) produced at the onset of colitis interferes with bile-acid detoxification through the receptor-interacting serine/threonine-protein kinase 1/extracellular signal-regulated kinase pathway in intestinal epithelial cells, leading to bile acid overload in the endoplasmic reticulum and consequent apoptosis. In line with the synergy of bile acids and TNF in promoting gut epithelial damage, high intestinal bile acids correlate with poor infliximab response, and bile acid clearance improves infliximab efficacy in experimental colitis. This study identifies bile acids as an ‘‘opportunistic pathogenic factor’’ in the gut that would represent a promising target and stratification criterion for ulcerative colitis prevention/therapy. |
Keyword | Bile Acid Detoxification Infliximab Tumor Necrosis Factor Ulcerative Colitis |
DOI | 10.1016/j.cmet.2024.06.008 |
URL | View the original |
Indexed By | SCIE |
Language | 英語English |
WOS Research Area | Cell Biology ; Endocrinology & Metabolism |
WOS Subject | Cell Biology ; Endocrinology & Metabolism |
WOS ID | WOS:001306813000001 |
Publisher | CELL PRESS, 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 |
Scopus ID | 2-s2.0-85198577770 |
Fulltext Access | |
Citation statistics | |
Document Type | Journal article |
Collection | Faculty of Health Sciences Cancer Centre DEPARTMENT OF BIOMEDICAL SCIENCES Ministry of Education Frontiers Science Center for Precision Oncology, University of Macau |
Corresponding Author | Heikenwalder, Mathias; Li, Yanqing; Yuan, Detian; Li, Shiyang |
Affiliation | 1.Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, 250012, China 2.Shandong Provincial Clinical Research Center for Digestive Diseases, Jinan, China 3.Advanced Medical Research Institute, Shandong University, Jinan, 250012, China 4.Laboratory of Translational Gastroenterology, Qilu Hospital of Shandong University, Jinan, 250012, China 5.Robot Engineering Laboratory for Precise Diagnosis and Therapy of GI Tumor, Qilu Hospital of Shandong University, Jinan, 250012, China 6.Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany 7.Institute for Immunology, School of Medicine, Tsinghua University, Beijing, 100084, China 8.CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031, China 9.Institute of Pathology and Pathophysiology, Shandong University School of Medicine, Jinan, 250012, China 10.Cancer Centre, Faculty of Health Sciences University of Macau, Macau SAR, China 11.The M3 Research Center, Medical faculty, University Tübingen, Tübingen, Ottfried-Müller Strasse 37, Germany 12.Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Shandong University, Jinan, 250012, China 13.Key Laboratory for Experimental Teratology of Ministry of Education, Shandong University, Jinan, 250012, China 14.Beijing Key Laboratory for Immunological Research on Chronic Diseases, Tsinghua University, Beijing, 100084, China 15.Department of Pathology, Qilu Hospital of Shandong University, Jinan, 250012, China 16.MOE Frontier Science Centre for Precision Oncology, University of Macau, Macau SAR, China |
Recommended Citation GB/T 7714 | Zheng, Mengqi,Zhai, Yunjiao,Yu, Yanbo,et al. TNF compromises intestinal bile-acid tolerance dictating colitis progression and limited infliximab response[J]. Cell Metabolism, 2024, 36(9), 2086-2103. |
APA | Zheng, Mengqi., Zhai, Yunjiao., Yu, Yanbo., Shen, Jing., Chu, Shuzheng., Focaccia, Enrico., Tian, Wenyu., Wang, Sui., Liu, Xuesong., Yuan, Xi., Wang, Yue., Li, Lixiang., Feng, Bingcheng., Li, Zhen., Guo, Xiaohuan., Qiu, Ju., Zhang, Cuijuan., Hou, Jiajie., Sun, Yiyuan., ...& Li, Shiyang (2024). TNF compromises intestinal bile-acid tolerance dictating colitis progression and limited infliximab response. Cell Metabolism, 36(9), 2086-2103. |
MLA | Zheng, Mengqi,et al."TNF compromises intestinal bile-acid tolerance dictating colitis progression and limited infliximab response".Cell Metabolism 36.9(2024):2086-2103. |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment